MichaelRayPowersMD
Pediatric Pulmonology • Portland, ORProfessor, Pediatrics, Oregon Health and Science University School of Medicine
Dr. Powers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-418-5747
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Pediatric Pulmonology, 1991- Oregon Health & Science University (OHSU Health)Residency, Pediatrics, 1985 - 1988
Oregon Health and Science University School of MedicineClass of 1985
Certifications & Licensure
OR State Medical License 1986 - 2025- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) Start of enrollment: 2014 Jan 01
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
Publications & Presentations
PubMed
- 27 citationsFavorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic.Ryan C Perkins, Jaclyn Davis, Andrew NeSmith, Julianna Bailey, Michael R. Powers
Annals of the American Thoracic Society. 2021-09-01 - 26 citationsLong-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR ...Patrick A. Flume, Reta Fischer Biner, Damian G Downey, Cynthia A. Brown, Manu Jain
The Lancet. Respiratory Medicine. 2021-02-10 - 30 citationsChanges in Lung Clearance Index in Preschool-aged Patients with Cystic Fibrosis Treated with Ivacaftor (GOAL): A Clinical Trial.Felix Ratjen, Michelle Klingel, Philip Black, Michael R. Powers, Hartmut Grasemann
American Journal of Respiratory and Critical Care Medicine. 2018-08-15
Grant Support
- Regulation Of Vessel Regression In Ischemic RetinopathyNational Eye Institute2006–2011
- Growth Factors In Oxygen Injured Neonatal EyesNational Eye Institute1998–2002
- Growth Factors In Neonatal Hyperoxic Eye And Lung InjuryNational Eye Institute1991–1995
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
